BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 5959966)

  • 1. Influence of treatment with an amino oxidase inhibitor on the excretion of bufotenin and the clinical symptoms in chronic schizophrenic patients.
    Heller B
    Int J Neuropsychiatry; 1966 Apr; 2(2):193-203. PubMed ID: 5959966
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of trifluperidol (R 2498) on the urinary elimination of bufotenin in schizophrenia.
    Acebal EM; Spatz H
    Int J Neuropsychiatry; 1967 Dec; 3(6):472-6. PubMed ID: 5583441
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of bufotenin in the urine of schizophrenics.
    Fischer E; Spatz H
    Int J Neuropsychiatry; 1967 Jun; 3(3):226-8. PubMed ID: 6034731
    [No Abstract]   [Full Text] [Related]  

  • 4. [N,N-dimethyltryptamine and bufotenin in the urine of patients with chronic and acute schizophrenic psychoses].
    Rosengarten H; Szemis A; Piotrowski A; Romaszewska K; Matsumoto H; Stencka K; Jus A
    Psychiatr Pol; 1970; 4(5):519-21. PubMed ID: 5483205
    [No Abstract]   [Full Text] [Related]  

  • 5. [A therapeutic pathomorphosis of schizophrenia proceeding with paranoid disorders].
    Ozola MIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(4):600-5. PubMed ID: 5497116
    [No Abstract]   [Full Text] [Related]  

  • 6. Gas chromatographic-mass spectrometric identification of urinary bufotenin and dimethyltryptamine in drug-free chronic schizophrenic patients.
    Narasimhachari N; Baumann P; Pak HS; Carpenter WT; Zocchi AF; Hokanson L; Fujimori M; Himwich HE
    Biol Psychiatry; 1974 Jun; 8(3):293-305. PubMed ID: 4527813
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies of drug-free schizophrenics and controls.
    Narasimhachari N; Avalos J; Fujimori M; Himwich HE
    Biol Psychiatry; 1973 Dec; 5(3):311-8. PubMed ID: 4513564
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study on the presence of bufotenin in the urine of schizophrenic patients].
    Sireix DW; Marini FA
    Rev Sanid Milit Argent; 1967; 66(1):14-21. PubMed ID: 5629061
    [No Abstract]   [Full Text] [Related]  

  • 9. [Predicting the effect of psychopharmacotherapy in schizophrenic patients].
    Dikiĭ NT
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(1):110-5. PubMed ID: 6121436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [THE EFFECT OF A MONOAMINE OXIDASE INHIBITOR ON THE ELIMINATION OF BUFOTENIN AND ON THE SYMPTOMS OF CHRONIC NON-PRODUCTIVE SCHIZOPHRENIA].
    FISCHER E; HELLER B
    Ann Med Psychol (Paris); 1965 Apr; 123():614-22. PubMed ID: 14296667
    [No Abstract]   [Full Text] [Related]  

  • 11. Nicotinic acid as an adjuvant in the treatment of chronic schizophrenic patients with special reference to changes in higher nervous activity.
    Saarma J; Vasar H
    Curr Ther Res Clin Exp; 1970 Nov; 12(11):729-33. PubMed ID: 4993126
    [No Abstract]   [Full Text] [Related]  

  • 12. Bufotenin like substances in form of glucuronide in schizophrenic and normal urines.
    Fischer E; Spatz H; Fledel T
    Psychosomatics; 1971; 12(4):278-80. PubMed ID: 5172934
    [No Abstract]   [Full Text] [Related]  

  • 13. The determination of bufotenin in urine of schizophrenic patients and normal controls.
    Narasimhachari N; Himwich HE
    J Psychiatr Res; 1972 Jun; 9(2):113-21. PubMed ID: 5071936
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroleptic therapy for chronic schizophrenia.
    Ayd FJ
    Dis Nerv Syst; 1972 Jan; 33(1):35-9. PubMed ID: 5059687
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the elimination of bufotenin in urine.
    Sireix DW; Marini FA
    Behav Neuropsychiatry; 1969 Aug; 1(5):29-31. PubMed ID: 5398115
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenelzine as a possible treatment for depression in schizophrenic patients.
    Melamed Y; Karniel E; Szor H
    Isr J Psychiatry Relat Sci; 1996; 33(3):211-2. PubMed ID: 9009521
    [No Abstract]   [Full Text] [Related]  

  • 17. Urinary excretion of catecholamines and their metabolites in chronic schizophrenics treated with oxypertine and chlorpromazine.
    Kiriike N; Uete T; Motomura K; Enomoto M; Murata K
    Biol Psychiatry; 1984 Mar; 19(3):417-22. PubMed ID: 6144330
    [No Abstract]   [Full Text] [Related]  

  • 18. [Urinary excretion of 5-hydroxyindoleacetic acid by patients with chronic schizophrenia].
    Slowik S
    Psychiatr Pol; 1967; 1(1):45-52. PubMed ID: 5597271
    [No Abstract]   [Full Text] [Related]  

  • 19. [On peculiarities of the clinical picture and course of circular schizophrenia and the effect of active therapy on it].
    Barshteĭn EI; Eryshev OF
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(2):256-9. PubMed ID: 6000911
    [No Abstract]   [Full Text] [Related]  

  • 20. Occurrence of bufotenin in the urine of schizophrenic patients and normal persons.
    Faurbye A; Pind K
    Nature; 1968 Nov; 220(5166):489. PubMed ID: 5686166
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.